长期补充低剂量褪黑素对大鼠心跳骤停后线粒体功能的保护作用
Protective Effect of Long-Term Low-Dose Melatonin Supplementation on Mitochondrial Function after Cardiac Arrest in Rats
DOI: 10.12677/ACM.2023.13102190, PDF,   
作者: 胡亚楠, 刘 毅, 徐龙河*:中国人民解放军总医院第三医学中心麻醉科,北京
关键词: 心肺复苏心跳骤停褪黑素缺血–再灌注线粒体CPR Cardiac Arrest Melatonin Ischemia-Reperfusion Mitochondria
摘要: 目的:通过长期服用保健药物来预防心跳骤停诱发的死亡是错综复杂且较少探索的复苏策略。褪黑激素是一种改善睡眠的保健品,有研究报道其在冬眠动物的唤醒期不断升高,在血液回流后可以提高存活率,并减少再灌注损伤。本研究旨在探索每日预防性补充保健药物褪黑激素对减少心跳骤停危害的影响。方法:研究对象为SD雄性大鼠,240~340克。共分为3组:对照组(Sham组);心跳骤停组(CA组);和药物预处理组(Mel组)。Mel组,大鼠每天接受腹腔注射10 mg/kg的褪黑素,持续14天。8分钟窒息诱导心跳骤停后进行手动心肺复苏。复苏后24小时进行神经学评分,取海马组织观测线粒体的完整性、动力学改变和功能损伤。结果:Mel组的存活率高于CA组(38.89% vs. 31.81%, P = 0.641)。ΔΨm在CA组、Mel组低于Sham组(P < 0.05)。ROS、线粒体肿胀和线粒体呼吸速率在CA组低于Sham组(P < 0.05)。ΔΨm、线粒体肿胀、线粒体呼吸速率在Mel组高于CA组(P > 0.05)。ROS在Mel组低于CA组(P = 0.535)。结论:心跳骤停复苏后加重了线粒体损伤。长期补充低剂量褪黑素改善了大鼠心跳骤停后线粒体功能。
Abstract: Objective: Prophylactic pharmacotherapy for health care in reducing death after cardiac arrest (CA) is an elusive and less explored strategy. Melatonin, a natural health product contributing to sleep, was elevated upon arousal from torpor in hibernating mammals, which increased survival after blood return and reduced reperfusion injury. In this study, we sought to find the effects of long-term daily prophylactic supplement with melatonin as a health care medicine on the victim of CA. Meth-ods: SD rats, 240~340 g, were used in this study. Sham, CA, and melatonin + CA (Mel) groups were included. The rats in the Mel group received daily IP injection of melatonin 10 mg/kg for 14 days. CA was induced by 8 mins asphyxia and followed by manual CPR. The endpoint was 24 h after re-suscitation. Neurological outcome was assessed. Hippocampal mitochondrial function was observed. Results: Survival in the Mel group was higher than in the CA group (38.89% vs. 31.81%, P = 0.641). ΔΨm was lower in the CA group and Mel group than in the Sham group (P < 0.05). ΔΨm, mitochon-drial swelling and mitochondria respiratory rate were higher in the Mel group than in the CA group (P > 0.05). ROS production was lower in the Mel group (P = 0.535). Conclusions: CA induced mito-chondrial injury. Long-term daily prophylactic supplement with low dosage of melatonin improved neuronal mitochondrial function after CA.
文章引用:胡亚楠, 刘毅, 徐龙河. 长期补充低剂量褪黑素对大鼠心跳骤停后线粒体功能的保护作用[J]. 临床医学进展, 2023, 13(10): 15660-15667. https://doi.org/10.12677/ACM.2023.13102190

参考文献

[1] Kragholm, K., Wissenberg, M., Mortensen, R.N., Hansen, S.M., Malta Hansen, C., Thorsteinsson, K., Rajan, S., Lippert, F., Folke, F., Gislason, G., Kober, L., Fonager, K., Jensen, S.E., Gerds, T.A., Torp-Pedersen, C. and Rasmussen, B.S. (2017) Bystander Efforts and 1-Year Outcomes in Out-of-Hospital Cardiac Arrest. The New England Journal of Medi-cine, 376, 1737-1747. [Google Scholar] [CrossRef
[2] Renn, T.Y., Huang, Y.K., Feng, S.W., Wang, H.W., Lee, W.F., Lin, C.T., Burnouf, T., Chen, L.Y., Kao, P.F. and Chang, H.M. (2018) Prophylactic Supplement with Melatonin Successfully Suppresses the Pathogenesis of Periodontitis through Normalizing RANKL/OPG Ratio and De-pressing the TLR4/MyD88 Signaling Pathway. Journal of Pineal Research, 64, e12464. [Google Scholar] [CrossRef] [PubMed]
[3] Tan, D.X., Manchester, L.C., Sainz, R.M., Mayo, J.C., Leon, J. and Reiter, R.J. (2005) Physiological Ischemia/Reperfusion Phenomena and Their Relation to Endogenous Melatonin Production: A Hypothesis. Endocrine, 27, 149-157. [Google Scholar] [CrossRef
[4] Hsu, J.T., Kuo, C.J., Chen, T.H., Wang, F., Lin, C.J., Yeh, T.S., Hwang, T.L. and Jan, Y.Y. (2012) Melatonin Prevents Hemorrhagic Shock-Induced Liver Injury in Rats through an Akt-Dependent HO-1 Pathway. Journal of Pineal Research, 53, 410-416. [Google Scholar] [CrossRef
[5] Klein, A.H., Wendroth, S.M., Drewes, L.R. and Andrews, M.T. (2010) Small-Volume d-β-Hydroxybutyrate Solution Infusion Increases Survivability of Lethal Hemorrhagic Shock in Rats. Shock, 34, 565-572. [Google Scholar] [CrossRef
[6] Mulier, K.E., Lexcen, D.R., Luzcek, E., Greenberg, J.J. and Beilman, G.J. (2012) Treatment with β-Hydroxybutyrate and Melatonin Is Associated with Improved Survival in a Por-cine Model of Hemorrhagic Shock. Resuscitation, 83, 253-258. [Google Scholar] [CrossRef] [PubMed]
[7] Hadj-Moussa, H. and Storey, K.B. (2019) Bringing Nature Back: Using Hibernation to Reboot Organ Preservation. The FEBS Journal, 286, 1094-1100. [Google Scholar] [CrossRef] [PubMed]
[8] Maronde, E. and Stehle, J.H. (2007) The Mammalian Pineal Gland: Known Facts, Unknown Facets. Trends in Endocrinology and Metabolism, 18, 142-149. [Google Scholar] [CrossRef] [PubMed]
[9] Chonde, M., Flickinger, K.L., Sundermann, M.L., Koller, A.C., Salcido, D.D., Dezfulian, C., Menegazzi, J.J. and Elmer, J. (2019) Intra-Arrest Administration of Cyclosporine and Methylprednisolone Does Not Reduce Postarrest Myocardial Dysfunction. BioMed Research International, 2019, Article ID: 6539050. [Google Scholar] [CrossRef] [PubMed]
[10] Hardeland, R., Tan, D.X. and Reiter, R.J. (2009) Kynuramines, Metab-olites of Melatonin and Other Indoles: The Resurrection of an Almost Forgotten Class of Biogenic Amines. Journal of Pineal Research, 47, 109-126. [Google Scholar] [CrossRef
[11] Paredes, S.D., Marchena, A.M., Bejarano, I., Espino, J., Barriga, C., Rial, R.V., Reiter, R.J. and Rodriguez, A.B. (2009) Melatonin and Tryptophan Affect the Activity-Rest Rhythm, Core and Peripheral Temperatures, and Interleukin Levels in the Ringdove: Changes with Age. The Journals of Gerontology: Series A, 64A, 340-350. [Google Scholar] [CrossRef] [PubMed]
[12] Jan, J.E., Reiter, R.J., Wasdell, M.B. and Bax, M. (2009) The Role of the Thalamus in Sleep, Pineal Melatonin Production, and Circadian Rhythm Sleep Disorders. Journal of Pineal Research, 46, 1-7. [Google Scholar] [CrossRef
[13] Witt-Enderby, P.A., Radio, N.M., Doctor, J.S. and Davis, V.L. (2006) Therapeutic Treatments Potentially Mediated by Melatonin Receptors: Potential Clinical Uses in the Preven-tion of Osteoporosis, Cancer and as an Adjuvant Therapy. Journal of Pineal Research, 41, 297-305. [Google Scholar] [CrossRef
[14] Ren, C., Li, S., Rajah, G., Shao, G., Lu, G., Han, R., Huang, Q., Li, H., Ding, Y., Jin, K. and Ji, X. (2018) Hypoxia, Hibernation and Neuroprotection: An Experimental Study in Mice. Aging and Disease, 9, 761-768. [Google Scholar] [CrossRef
[15] Frerichs, K.U., Kennedy, C., Sokoloff, L. and Hallenbeck, J.M. (1994) Local Cerebral Blood Flow during Hibernation, a Model of Natural Tolerance to “Cerebral Ischemia”. Journal of Cere-bral Blood Flow and Metabolism, 14, 193-205. [Google Scholar] [CrossRef] [PubMed]
[16] Pevet, P. and Challet, E. (2011) Melatonin: Both Master Clock Output and Internal Time-Giver in the Circadian Clocks Network. Journal of physiology-Paris, 105, 170-182. [Google Scholar] [CrossRef] [PubMed]
[17] Patil, K.D., Halperin, H.R. and Becker, L.B. (2015) Cardiac Arrest: Resuscitation and Reperfusion. Circulation Research, 116, 2041-2049. [Google Scholar] [CrossRef
[18] Reiter, R.J., Tan, D.X., Manchester, L.C. and El-Sawi, M.R. (2002) Melatonin Reduces Oxidant Damage and Promotes Mitochondrial Respiration: Implications for Aging. An-nals of the New York Academy of Sciences, 959, 238-250. [Google Scholar] [CrossRef] [PubMed]
[19] Suofu, Y., Li, W., Jean-Alphonse, F.G., Jia, J., Khattar, N.K., Li, J., Baranov, S.V., Leronni, D., Mihalik, A.C., He, Y., Cecon, E., Wehbi, V.L., Kim, J., Heath, B.E., Baranova, O.V., Wang, X., Gable, M.J., Kretz, E.S., Di Benedetto, G., Lezon, T.R., Ferrando, L.M., Larkin, T.M., Sullivan, M., Yablonska, S., Wang, J., Minnigh, M.B., Guillaumet, G., Suzenet, F., Richardson, R.M., Poloyac, S.M., Stolz, D.B., Jockers, R., Witt-Enderby, P.A., Carlisle, D.L., Vilardaga, J.P. and Friedlander, R.M. (2017) Dual Role of Mitochondria in Producing Melatonin and Driving GPCR Signaling to Block Cytochrome c Release. Proceedings of the National Academy of Sciences of the United States of America, 114, E7997-E8006. [Google Scholar] [CrossRef] [PubMed]
[20] Slominski, R.M., Reiter, R.J., Schlabritz-Loutsevitch, N., Ostrom, R.S. and Slominski, A.T. (2012) Melatonin Membrane Receptors in Peripheral Tissues: Distribution and Functions. Mo-lecular and Cellular Endocrinology, 351, 152-166. [Google Scholar] [CrossRef] [PubMed]
[21] Perez-Gonzalez, A., Castaneda-Arriaga, R., Alvarez-Idaboy, J.R., Reiter, R.J. and Galano, A. (2019) Melatonin and Its Metabolites as Chemical Agents Capable of Directly Repairing Oxidized DNA. Journal of Pineal Research, 66, e12539. [Google Scholar] [CrossRef] [PubMed]
[22] Wang, X., Sirianni, A., Pei, Z., Cormier, K., Smith, K., Jiang, J., Zhou, S., Wang, H., Zhao, R., Yano, H., Kim, J.E., Li, W., Kristal, B.S., Ferrante, R.J. and Friedlander, R.M. (2011) The Melato-nin MT1 Receptor Axis Modulates Mutant Huntingtin-Mediated Toxicity. The Journal of Neuroscience, 31, 14496-14507. [Google Scholar] [CrossRef
[23] Zhong, J., Tan, Y., Lu, J., Liu, J., Xiao, X., Zhu, P., Chen, S., Zheng, S., Chen, Y., Hu, Y. and Guo, Z. (2019) Therapeutic Contribution of Melatonin to the Treatment of Septic Cardiomyopathy: A Novel Mechanism Linking Ripk3-Modified Mitochondrial Performance and Endoplasmic Re-ticulum Function. Redox Biology, 26, Article ID: 101287. [Google Scholar] [CrossRef] [PubMed]